Author Archives: Science Media Centre

expert reaction to the Government’s COVID-19 Winter Plan

The government have released a COVID-19 Winter Plan.   Dr Julian Tang, Honorary Associate Professor/ Clinical Virologist, Respiratory Sciences, University … read more

Posted in RoundUps | Tagged , | Leave a comment

AstraZeneca and University of Oxford media briefing

Journalists from around the world were invited to join a media briefing webinar on the positive high-level results from an … read more

Posted in Briefings | Tagged , , | Leave a comment

expert reaction to phase 3 interim analysis of the Oxford/AstraZeneca COVID-19 vaccine

Experts commented on the phase 3 interim analysis of the Oxford / AstraZeneca COVID-19 vaccine read more

Posted in RoundUps | Tagged , | Leave a comment

AstraZeneca Antibody Study

We have heard a lot about vaccines for the elderly. But there are also prophylactic drugs being tested that could … read more

Posted in Briefings | Tagged , | Leave a comment

expert reaction to preprint looking at COVID-19 antibodies and protection against reinfection

A preprint, an unpublished non-peer reviewed study, posted on medRxiv looks at antibodies to SARS-CoV-2 and protection against reinfection.   … read more

Posted in RoundUps | Tagged , | Leave a comment

expert reaction to study looking at MMR antibodies and COVID-19 disease severity

A study published in mBio looks at Measles-Mumps-Rubella (MMR) antibodies and COVID-19 disease severity.   Dr Penny Ward, Visiting Professor … read more

Posted in RoundUps | Tagged , , | Leave a comment

expert reaction to latest R number and growth rate estimates published by the government

The government have released the latest estimates for the COVID-19 growth rate and R value.   Prof Oliver Johnson, Professor … read more

Posted in RoundUps | Tagged , | Leave a comment

annual reports and accounts 2019-20

Posted in Annual Reports | Leave a comment

expert reaction to latest data from the ONS COVID-19 Infection Survey

The Office for National Statistics (ONS) have released the latest data from their COVID-19 Infection Survey.   Dr Simon Clarke, Associate … read more

Posted in RoundUps | Tagged , | Leave a comment

expert comments about COVID-19 and Christmas

A few journalists have asked us what COVID-19 means for Christmas this year, so here a few general comments from … read more

Posted in RoundUps | Tagged , | Leave a comment

expert reaction to WHO Guideline Development Group advising against use of remdesivir for COVID-19

The World Health Organisation (WHO) have released an updated guideline on drugs for COVID-19, published in the BMJ, in which … read more

Posted in RoundUps | Tagged , | Leave a comment

expert reaction to a preprint on responsive T cell numbers and associated protection from COVID-19, as referred to in the PHE ‘Evaluating detection of SARS-CoV-2: AntiBodies at Home study’ report which was updated yesterday

A preprint, an unpublished non-peer reviewed study, posted on MedRxiv looks at responsive T cell numbers and associated protection from … read more

Posted in RoundUps | Tagged , | Leave a comment

expert reaction to REMAP-CAP trial reporting that critically ill COVID-19 patients treated with tocilizumab are more likely to have improved outcomes

The REMAP-CAP trial has reported that critically ill COVID-19 patients treated with tocilizumab are more likely to have improved outcomes. … read more

Posted in RoundUps | Tagged , | Leave a comment

results from REMAP-CAP trial – tocilizumab for patients with severe COVID-19

The REMAP-CAP trial, which began investigating treatments for COVID-19 in March, has been trialling potential treatments in hospitalised patients with … read more

Posted in Briefings | Tagged , | Leave a comment

phase 2 trial safety and immunogenicity data from the Oxford COVID-19 vaccine trial including in healthy older adults

The Oxford vaccine have published data from the phase 2 trial of their COVID-19 vaccine candidate, the ChAdOx1 nCoV-19 vaccine.  … read more

Posted in Briefings | Tagged , , | Leave a comment

expert reaction to paper using an RCT to assess mask use as a public health measure to help control SARS-CoV-2 spread (DANMASK-19)

A randomised control trial (RCT) published by Annals of Internal Medicine assesses mask use as a public health measure to … read more

Posted in RoundUps | Tagged , | Leave a comment

expert reaction to phase 2 trial safety and immunogenicity data from the Oxford COVID-19 vaccine trial including in healthy older adults

The phase 2 trial safety and immunogenicity data from the Oxford COVID-19 vaccine trial has been published in the Lancet, … read more

Posted in RoundUps | Tagged , , | Leave a comment

expert reaction to announcement by Pfizer that they have concluded the Phase III study of their COVID-19 vaccine candidate after demonstrating 95% efficacy

Pfizer and BioNTech have announced that they have concluded phase 3 study of their COVID-19 vaccine candidate, demonstrating 95% efficacy. … read more

Posted in RoundUps | Tagged , , | Leave a comment

expert reaction to a preprint investigating immunological memory to SARS-CoV-2 after six months

A preprint, an unpublished non-peer reviewed study,  posted on bioRxiv looks at immunological memory to SARS-CoV-2 over six months after … read more

Posted in RoundUps | Tagged , | Leave a comment

expert reaction to the government’s ‘ten point plan for a Green Industrial Revolution’

Boris Johnson has announced the government’s ten point plan for a green economy, jobs and industry.   Prof Rob Gross, … read more

Posted in RoundUps | Tagged , , | Leave a comment